CellTran Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$288K
CellTran General Information
Description
Developer of cell therapy products for treatment of burns and ulcers. The company develops treatment for chronic, complex or non-healing wounds using advanced polymer surface technology and the autologous and allogeneic cells cultured from the patients living cells, providing patients suffering from chronic burns with skin transplants that avoids hostile reactions from the body.
Contact Information
Website
www.celltran.co.ukCorporate Office
- The Innovation Centre
- 217 Portobello
- Sheffield S1 4DP
- England, United Kingdom
Corporate Office
- The Innovation Centre
- 217 Portobello
- Sheffield S1 4DP
- England, United Kingdom
CellTran Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 28-Oct-2008 | $288K | Completed | Bankruptcy: Admin/Reorg | ||
| 6. Bankruptcy: Admin/Reorg | 16-Jun-2008 | Completed | Bankruptcy: Admin/Reorg | |||
| 5. Later Stage VC | 24-Aug-2007 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 04-Aug-2005 | Completed | Product Development | |||
| 3. Early Stage VC | 01-Feb-2005 | Completed | Product Development | |||
| 2. Early Stage VC | 01-Jan-2004 | $1.05M | $1.43M | Completed | Product Development | |
| 1. Seed Round | 01-Aug-2000 | $377K | $377K | Completed | Startup |
CellTran Patents
CellTran Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-0313569-D0 | Method | Inactive | 12-Jun-2003 | ||
| AU-2004217726-A1 | Cell culture | Inactive | 05-Mar-2003 | ||
| CA-2517982-A1 | Cell culture | Inactive | 05-Mar-2003 | ||
| EP-1601763-A2 | Cell culture | Inactive | 05-Mar-2003 | ||
| GB-0304918-D0 | Cell culture | Inactive | 05-Mar-2003 | A61L27/3886 |
CellTran Signals
CellTran Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Finance Yorkshire | Growth/Expansion | Minority | ||
| FusionIP | Venture Capital | Minority | ||
| Innogenetics | Corporation | Minority | ||
| PUK Ventures | Fund of Funds | Minority | ||
| Wellcome Trust | Limited Partner | Minority |
CellTran Acquisitions (1)
CellTran’s most recent deal was a Merger/Acquisition with XCELLentis. The deal was made on 02-Oct-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| XCELLentis | 02-Oct-2006 | Merger/Acquisition | Drug Discovery |
CellTran FAQs
-
When was CellTran founded?
CellTran was founded in 2000.
-
Where is CellTran headquartered?
CellTran is headquartered in Sheffield, United Kingdom.
-
What is the size of CellTran?
CellTran has 12 total employees.
-
What industry is CellTran in?
CellTran’s primary industry is Drug Discovery.
-
Is CellTran a private or public company?
CellTran is a Private company.
-
What is the current valuation of CellTran?
The current valuation of CellTran is .
-
What is CellTran’s current revenue?
The current revenue for CellTran is .
-
How much funding has CellTran raised over time?
CellTran has raised $8.65M.
-
Who are CellTran’s investors?
Finance Yorkshire, FusionIP, Innogenetics, PUK Ventures, and Wellcome Trust are 5 of 7 investors who have invested in CellTran.
-
When was CellTran acquired?
CellTran was acquired on 28-Oct-2008.
-
Who acquired CellTran?
CellTran was acquired by York Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process